Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,234,421,512
+$346,554,284 QoQ
Shares Held
12,853,368
-3.2% QoQ
Ownership
0.727%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#20
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 1%
None 9%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. ABBV ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,234,421,512 | 12,853,368 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,887,867,228 | 13,278,161 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,084,466,698 | 13,499,351 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,848,386,316 | 12,301,919 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,321,455,962 | 12,506,497 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $2,773,563,525 | 13,237,703 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,428,075,020 | 13,663,900 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $3,370,109,345 | 17,065,573 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,006,549,029 | 17,528,854 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,611,605,133 | 19,833,087 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $3,425,532,958 | 22,104,491 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $3,034,276,083 | 20,356,072 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,695,038,535 | 20,003,255 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $3,217,370,954 | 20,188,059 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,271,330,455 | 20,242,129 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,776,730,807 | 20,689,448 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,260,528,578 | 21,288,382 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,211,176,191 | 19,808,625 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,895,505,568 | 21,384,827 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,275,028,775 | 21,090,468 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,364,934,691 | 20,995,514 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,229,507,311 | 20,601,620 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,224,773,124 | 20,763,165 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,842,655,262 | 21,037,279 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $2,099,830,930 | 21,387,563 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,416,380,855 | 18,590,115 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||